Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers
Ortmann, O., Blohmer, J.-U., Sibert, N. T., Brucker, S., Janni, W., Wöckel, A., Scharl, A., Dieng, S., Ferencz, J., Inwald, E. C., Wesselmann, S., Kowalski, C.
Published in Journal of cancer research and clinical oncology (01.03.2023)
Published in Journal of cancer research and clinical oncology (01.03.2023)
Get full text
Journal Article
Protroca: A non-interventional study on prophylaxis of chemotherapy induced neutropenia using lipegfilgrastim in non-selected breast cancer patients
Wuerstlein, R., Harbeck, N., Grischke, E.-M., Forstmeyer, D., von Schumann, R., Krabisch, P., Nitz, U., Gluz, O., Kates, R.E., Graeser, M.
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
Quality of life and symptoms in longterm survivors with ovarian cancer: It’s still an issue. Expression VI – Carolin meets HANNA – holistic analysis of long-term survival with ovarian cancer: The international NOGGO, ENGOT and GCIG survey
Woopen, H., Braicu, I., Richter, R., Schnuppe, K., Krabisch, P., Boxler, T., Emons, G., Glajzer, J., Rose, M., Erdur, L., Lindhorst, R., Endres, M., Hühnchen, P., Vergote, I.B., Berger, R., Marth, C., Sehouli, J.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Complementary and alternative medicine and musculoskeletal pain in the first year of adjuvant aromatase inhibitor treatment in early breast cancer patients
Hack, C.C., Häberle, L., Brucker, S.Y., Janni, W., Volz, B., Loehberg, C.R., Hartkopf, A.D., Walter, C.-B., Baake, G., Fridman, A., Malter, W., Wuerstlein, R., Harbeck, N., Hoffmann, O., Kuemmel, S., Martin, B., Thomssen, C., Graf, H., Wolf, C., Lux, M.P., Bayer, C.M., Rauh, C., Almstedt, K., Gass, P., Heindl, F., Brodkorb, T., Willer, L., Lindner, C., Kolberg, H.-C., Krabisch, P., Weigel, M., Steinfeld-Birg, D., Kohls, A., Brucker, C., Schulz, V., Fischer, G., Pelzer, V., Rack, B., Beckmann, M.W., Fehm, T., Rody, A., Maass, N., Hein, A., Fasching, P.A., Nabieva, N.
Published in Breast (Edinburgh) (01.04.2020)
Published in Breast (Edinburgh) (01.04.2020)
Get full text
Journal Article
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer
Nitz, Ulrike, Gluz, Oleg, Clemens, Michael, Malter, Wolfram, Reimer, Toralf, Nuding, Benno, Aktas, Bahriye, Stefek, Andrea, Pollmanns, Anke, Lorenz-Salehi, Fatemeh, Uleer, Christoph, Krabisch, Petra, Kuemmel, Sherko, Liedtke, Cornelia, Shak, Steven, Wuerstlein, Rachel, Christgen, Matthias, Kates, Ronald E, Kreipe, Hans H, Harbeck, Nadia
Published in Journal of clinical oncology (01.04.2019)
Published in Journal of clinical oncology (01.04.2019)
Get full text
Journal Article
208P ARB: Phase II window of opportunity study of preoperative treatment with enzalutamide in ER+ve and TNBC
Schmid, P., Gomez-Pardo, P., Wheatley, D., Roy, P., Krabisch, P., Thill, M., Ledwidge, S., Thompson, A., Macaskill, E.J., Viehstädt, N., Purushotham, A., Gluz, O., Stefek, A., Ackerman, C., Prendergast, A., Mousa, K., Jones, L., Viale, G., Cortés, J., Kümmel, S.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
247P Efficacy and safety of ribociclib (RIB) in combination with letrozole (LET) in patients with estrogen receptor–positive advanced breast cancer (ABC): Secondary and exploratory results of phase 3b RIBECCA study
Decker, T., Fasching, P.A., Nusch, A., Hartkopf, A., Heinrich, B.J., Kurbacher, C.M., Fuchs, R., Tesch, H., Krabisch, P., Huober, J., Kümmel, S., Brucker, S.Y., Janni, W., Schneeweiss, A., Schuler, M., Fehm, T.N., Lüftner, D., C. Quiering, Kreuzeder, J., Reinisch, M.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Differential impact of prognostic parameters in hormone receptor-positive lobular early breast cancer in the WSG PlanB trial
Christgen, M., Harbeck, N., Gluz, O., Raap, M., Christgen, H., Clemens, M., Malter, W., Nuding, B., Aktas, B., Kuemmel, S., Reimer, T., Stefek, A., Krabisch, P., Just, M., Graeser, M., Baehner, R., Wuerstlein, R., Nitz, U., Kates, R., Kreipe, H.
Published in European journal of cancer (1990) (01.10.2020)
Published in European journal of cancer (1990) (01.10.2020)
Get full text
Journal Article
206PProtroca: A non-interventional study on prophylaxis of chemotherapy induced neutropenia using lipegfilgrastim in non-selected breast cancer patients
Wuerstlein, R, Harbeck, N, Grischke, E-M, Forstmeyer, D, von Schumann, R, Krabisch, P, Nitz, U, Gluz, O, Kates, R E, Graeser, M
Published in Annals of oncology (01.05.2019)
Published in Annals of oncology (01.05.2019)
Get full text
Journal Article
939PDQuality of life and symptoms in longterm survivors with ovarian cancer: It's still an issue. Expression VI - Carolin meets HANNA - holistic analysis of long-term survival with ovarian cancer: The international NOGGO, ENGOT and GCIG survey
Woopen, H, Braicu, I, Richter, R, Schnuppe, K, Krabisch, P, Boxler, T, Emons, G, Glajzer, J, Rose, M, Erdur, L, Lindhorst, R, Endres, M, Hühnchen, P, Vergote, I B, Berger, R, Marth, C, Sehouli, J
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Abstract P2-10-03: Genomic markers but not molecular subtypes provide prognostic impact and predict anthracycline efficacy in early triple-negative breast cancer: Results from the prospective WSG PlanB trial
Gluz, O, Liedtke, C, Prat, A, Christgen, M, Gebauer, D, Kates, R, Pelz, E, Clemens, M, Warm, M, Aktas, B, Kuemmel, S, Pare, L, Krabisch, P, Kreipe, HH, Wuerstlein, R, Nitz, U, Harbeck, N
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Published in Cancer research (Chicago, Ill.) (15.02.2018)
Get full text
Journal Article
Prognostic impact of recurrence score (RS), grade/Ki67 central pathological review, and acycline (A)-free vs. A-containing chemotherapy (CT) on distant and locoregional disease-free survival (DDFS/LRFS) in high clinical risk HER2- early breast cancer (EBC): WSG PlanB trial results
Gluz, O., Nitz, U., Christgen, M., Malter, W., Clemens, M., Reimer, T., Nuding, B., Aktas, B., Stefek, A., Ppllmanns, A., Lorenz-Salehi, F., Uleer, C., Krabisch, P., Kümmel, S., Liedtke, C., Shak, S., Kates, R., Wurstlein, R., Kreipe, H.H., Harbeck, N.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
Abstract P1-13-01: Final results of the ASG1-3 study, a randomized phase III study comparing a standard dose chemotherapy with epirubicin/cyclophosphamide and paclitaxel with a dose dense regimen with epirubicin and paclitaxel
Fasching, PA, Eggemann, H, Krocker, J, Häberle, L, Volz, B, Kleine-Tebbe, A, Blohmer, J-U, Kittel, K, Hufnagel, M, Janni, W, Emons, G, Simon, E, Köhler, U, Thomssen, C, Kohls, A, Beckmann, MW, Hielscher, C, Krabisch, P, Zeiser, T, Brodkorb, T, Baier, F, Nabieva, N, Kellner, S, Untch, M, Stadie, S, Budner, M, Breitbach, G-P, Keller, M, Stickeler, E, Kühn, T, Tolkmitt, M, Belau, AK, Schmidt, M, Ulm, K, Kümmel, S
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab pre-treated patients with Her2-positive metastatic breast cancer - E-Vita
Bischoff, J., Barinoff, J., Mundhenke, C., Bauerschlag, D., Costa, S.D., Herr, D., Lübe, K., Marmé, F., Maass, N., von Minckwitz, G., Grischke, E.-M., Müller, V., Schmidt, M., Gerber, B., Kümmel, S., Schumacher, C., Krabisch, P., Thill, M., Nekljudova, V., Loibl, S.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Abstract P3-14-04: The choice of the indicator lesion impacts on the pCR rate – An analysis of 114 bilateral breast cancer patients treated within neoadjuvant trials
Loibl, S, Mergler, B, Eppel, A, Solbach, C, Lübbe, KM, Eidtmann, H, Rezai, M, Hanusch, C, Fehm, T, Bartzke, G, Burgmann, D-M, Krabisch, P, Untch, M, Nekljudova, V, von Minckwitz, G
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Published in Cancer research (Chicago, Ill.) (15.12.2013)
Get full text
Journal Article
P5-18-03: First Interim Toxicity Analysis of the Randomized Phase III WSG Plan B Trial Comparing 4xEC-4xDoc Versus 6xTC in Breast Cancer Patients with HER2 Negative Breast Cancer (BC)
Nitz, U, Gluz, O, Krepe, H, Liedtke, B, Aktas, B, Henschen, S, Pollmanns, A, Krabisch, P, Zuna, I, Shak, S, Thomsseen, C, Harbeck, N
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Implementation of a Composite Score System for Evaluation of Circulating Tumor Cells in Blood of Breast Cancer Patients
de Albuquerque, A., Kaul, S., Breier, G., Krabisch, P., Stryzhevska, N., Bastert, G., Fersis, N.
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Published in Cancer research (Chicago, Ill.) (15.12.2009)
Get full text
Journal Article
Characteristics of long-term survivors with ovarian cancer: Expression VI-Carolin meets HANNA – the international NOGGO, ENGOT and GCIG survey
Woopen, H, Richter, R, Braicu, EI, Keller, M, Glajzer, J, Rose, M, Erdur, L, Krabisch, P, Emons, G, Lindhorst, R, Endres, M, Hühnchen, P, Marth, C, Berger, R, Vergote, I, Sehouli, J
Published in Geburtshilfe und Frauenheilkunde (01.10.2018)
Published in Geburtshilfe und Frauenheilkunde (01.10.2018)
Get full text
Conference Proceeding
S3-6: Neoadjuvant Chemotherapy of Paclitaxel with or without Rad001: Results of the Non-Responder Part of the GEPARQUINTO Study (GBG 44)
Huober, J, Hanusch, C, Fasching, PA, Rezai, M, Eidtmann, H, Kittel, K, Schwedler, K, Tesch, H, Höß, C, Mau, C, Khandan, F, Krabisch, P, Loibl, S, Nekljudova, V, Untch, M, von Minckwitz, G
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article